We are live on
!
Find out more
MCO
MAK Capital One Portfolio holdings
AUM
$714M
1-Year Est. Return
68.07%
This Fund
S&P 500
This Quarter
Est. Return
+3.78%
1 Year Est. Return
+68.07%
3 Year Est. Return
+199.63%
5 Year Est. Return
+307.07%
10 Year Est. Return
+2,541.72%
AUM
$79.7M
AUM Growth
+$7.93M
(+11%)
Cap. Flow
+$9.12M
Cap. Flow
% of AUM
11.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$6.89M |
| 2 |
MXWL
Maxwell Technologies Inc
MXWL
|
+$2.23M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 79.06% |
| 2 | Industrials | 11.71% |
| 3 | Healthcare | 9.24% |
Similar funds
SAM
OL
LWM
HA
TC
FCFC
ADIC
ZAM
MAK Capital One's Q1 2018 Portfolio in Review
As of Q1 2018, MAK Capital One held 3 positions worth $79.7M, up 11% from $71.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
MAK Capital One deployed $9.12M of net new capital in Q1 2018, opening 1 new position and adding to 1 existing holding. Its largest new stake was PTC Therapeutics: 272,012 shares worth $7.36M.
By sector, the portfolio is most concentrated in Technology at 79% of assets, down from 90% a quarter earlier, followed by Industrials and Healthcare.
- MAK Capital One's largest Q1 2018 buy was PTC Therapeutics: 272,012 shares worth $7.36M.
- MAK Capital One added most to Maxwell Technologies Inc in Q1 2018, an estimated $2.23M increase.
- MAK Capital One's ten largest holdings make up 100% of its $79.7M portfolio in Q1 2018.
- MAK Capital One opened 1 new position and closed 0 in Q1 2018.
- MAK Capital One's portfolio value rose 11% quarter-over-quarter to $79.7M.
Based on MAK Capital One's 13F filing for Q1 2018, filed 15 May 2018.